PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)

• Isabel Syndikus,
• Clare Cruickshank,
• John Staffurth,
• Alison Tree,
• Ann Henry,
• Olivia Naismith,
• Helen Mayles,
• Nicola Snelson,
• Shama Hassan,
• Stephanie Brown,
• Nuria Porta,
• Clare Griffin,
• Emma Hall

Affiliations

Isabel Syndikus

The Clatterbridge Cancer Centre, Wirral, UK; Corresponding author at: The Clatterbridge Cancer Centre, Bebington, Wirral CH63 4JY, UK.

Clare Cruickshank

Clinical Trials and Statistics Unit, The Institute of Cancer Research (ICR-CTSU), London, UK

John Staffurth

Cardiff University/Velindre Cancer Centre, Cardiff, UK

Alison Tree

The Royal Marsden NHS Foundation Trust/The Institute of Cancer Research, London, UK

Ann Henry

The Leeds Teaching Hospitals NHS Trust, Leeds, UK

Olivia Naismith

National Radiotherapy Trials Quality Assurance Group, The Royal Marsden NHS Foundation Trust, London, UK

Helen Mayles

National Radiotherapy Trials Quality Assurance Group, The Clatterbridge Cancer Centre, Wirral. UK

Nicola Snelson

National Radiotherapy Trials Quality Assurance Group, The Clatterbridge Cancer Centre, Wirral. UK

Shama Hassan

Clinical Trials and Statistics Unit, The Institute of Cancer Research (ICR-CTSU), London, UK

Stephanie Brown

Clinical Trials and Statistics Unit, The Institute of Cancer Research (ICR-CTSU), London, UK

Nuria Porta

Clinical Trials and Statistics Unit, The Institute of Cancer Research (ICR-CTSU), London, UK

Clare Griffin

Clinical Trials and Statistics Unit, The Institute of Cancer Research (ICR-CTSU), London, UK

Emma Hall

Clinical Trials and Statistics Unit, The Institute of Cancer Research (ICR-CTSU), London, UK